GE HealthCare Technologies Inc.

Equities

GEHC

US36266G1076

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 04:00:00 2024-07-24 pm EDT 5-day change 1st Jan Change
79.69 USD -1.40% Intraday chart for GE HealthCare Technologies Inc. -3.37% +3.07%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
Volta Medical Enters into Joint Development Agreement with GE HealthCare to Enhance Arrhythmia Procedures with AI-Driven Electrophysiology Technologies CI
GE HealthCare to Acquire Intelligent Ultrasound Group's Clinical AI Software Business for $51 Million MT
GE HealthCare Technologies Inc. agreed to acquire Clinical Artificial Intelligence Business From Intelligent Ultrasound from Intelligent Ultrasound Group plc for £40.5 million. CI
BNP Paribas Initiates GE HealthCare Technologies at Outperform With $92 Price Target MT
BNP Paribas Exane Initiates GE HealthCare Technologies at Outperform With $92 Price Target MT
Goldman Sachs Adjusts Price Target on GE HealthCare Technologies to $83 From $87 MT
3M CFO Patolawala to leave company at end of July RE
UBS Adjusts Price Target on GE HealthCare Technologies to $84 From $88, Maintains Neutral Rating MT
GE HealthCare Technologies Inc.(NasdaqGS:GEHC) dropped from Russell Top 200 Growth Index CI
GE HealthCare Technologies Inc.(NasdaqGS:GEHC) dropped from Russell Top 200 Value Index CI
GE HealthCare Technologies Inc.(NasdaqGS:GEHC) dropped from Russell Top 200 Index CI
GE HealthCare Technologies Inc.(NasdaqGS:GEHC) added to Russell Midcap Growth Index CI
GE HealthCare Technologies Inc.(NasdaqGS:GEHC) added to Russell Midcap Index CI
GE HealthCare Technologies Inc.(NasdaqGS:GEHC) added to Russell Midcap Value Index CI
GE HealthCare Technologies Keeps Quarterly Dividend at $0.03 Per Share, Payable Aug. 15 to Shareholders of Record on July 19 MT
GE HealthCare Technologies Inc. Announces Cash Dividend for Second Quarter of 2024, Payable on August 15, 2024 CI
GE HealthCare Partners With New Mexico Hospital to Install Allia IGS Pulse Electrophysiology Lab MT
GE HealthCare, MediView Report Clinical Use of OmnifyXR Interventional Suite MT
GE Healthcare and Mediview Announce the World's First Installation and Clinical Use of Augmented Reality Interventional Suite That Aims to Transform the Practice of Interventional Radiology CI
GE HealthCare Reports Changes in Key Segments MT
GE Healthcare Technologies Inc. Announces Management Changes CI
Transcript : GE HealthCare Technologies Inc. Presents at Jefferies 2024 Global Healthcare Conference, Jun-05-2024 10:00 AM
Nucleus RadioPharma, Inc. announced that it has received $66.099956 million in funding from a group of investors CI
GE HealthCare, Tampa General Hospital Expand Collaboration in Imaging, Ultrasound Technology MT
GE Healthcare and Tampa General Hospital Expand Long-Term Partnership to Benefit Patients and Clinicians Across the State of Florida CI
Chart GE HealthCare Technologies Inc.
More charts
Logo GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc. is a medical technology, pharmaceutical diagnostics, and digital solutions company. It develops, manufactures, and markets a portfolio of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients. Its segments include Imaging, Ultrasound, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a comprehensive portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its Ultrasound segment includes ultrasound medical devices and solutions with a portfolio of continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment portfolio is comprised of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment is comprised of two business lines: contrast media and molecular imaging.
Employees
51,000
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
79.69USD
Average target price
92.52USD
Spread / Average Target
+16.10%
Consensus